T50 Stock Overview
A venture capital, private equity and advisory firm specializing in incubation, seed, start-ups, later stage, strategic advisory, global partnership development, breakthrough products, devices, treatments, health supplement, corporate restructuring, Corporate recapitalization and growth capital investments.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Right Season Investments Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.58 |
| 52 Week High | CA$2.80 |
| 52 Week Low | CA$0.35 |
| Beta | 1.21 |
| 1 Month Change | 32.42% |
| 3 Month Change | -11.45% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | -97.70% |
| Change since IPO | -99.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| T50 | DE Capital Markets | DE Market | |
|---|---|---|---|
| 7D | -4.1% | 0.3% | -0.3% |
| 1Y | n/a | 24.7% | 4.5% |
Return vs Industry: Insufficient data to determine how T50 performed against the German Capital Markets industry.
Return vs Market: Insufficient data to determine how T50 performed against the German Market.
Price Volatility
| T50 volatility | |
|---|---|
| T50 Average Weekly Movement | 16.8% |
| Capital Markets Industry Average Movement | 4.9% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: T50 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine T50's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | Tyler Lewis | www.rightseasoninvestmentscorp.com |
Right Season Investments Corp. is a venture capital, private equity and advisory firm specializing in incubation, seed, start-ups, later stage, strategic advisory, global partnership development, breakthrough products, devices, treatments, health supplement, corporate restructuring, Corporate recapitalization and growth capital investments. It focuses on managing and facilitating foreign investment and investing in private and public companies whose businesses involve later-stage. The firm prefers to invest in health & wellness, agricultural, medicinal mushroom, media, retail, financial services, pharmaceutical products, nutrition, medicine, technology, healthcare, clean tech, energy, consumer product, and consumer services and identify an exit strategy in China or North America.
Right Season Investments Corp. Fundamentals Summary
| T50 fundamental statistics | |
|---|---|
| Market cap | €2.06m |
| Earnings (TTM) | -€1.96m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.1x
P/E RatioIs T50 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| T50 income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$2.89m |
| Earnings | -CA$2.89m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.28 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 5.5% |
How did T50 perform over the long term?
See historical performance and comparison